Navigation Links
Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer
Date:3/15/2012

GREENWICH, Conn., March 15, 2012 /PRNewswire/ -- Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company's Clinical Trials Supply Business, Mr. Needleman has been promoted from his previous position at Aptuit as President, Scientific Operations. In his new role, Mr. Needleman is responsible for all day-to-day operations of the worldwide Aptuit organization, reporting directly to the company's Board.

(Logo:  http://photos.prnewswire.com/prnh/20120217/NY55633LOGO

In accepting this appointment, Mr. Needleman stated, "I am looking forward to this opportunity to lead the continued growth of Aptuit during the exciting days ahead. I believe that our comprehensive early to mid-phase drug development services, distinguished by our industry leading scientific expertise, are second to none. As we welcome new clients and continue our relationships with those who show their confidence in Aptuit again and again, we are enthusiastic about the future, and we remain dedicated to forging more robust strategic relationships."

In making the announcement, Tim Tyson reported that he will continue in his role as Chairman and will concentrate his efforts on a variety of external growth and strategic partnership opportunities. Mr. Tyson cited Mr. Needleman's recent success as President of Aptuit's Scientific Operations and his substantial industry standing. "Stu is a seasoned veteran with a legacy of more than 30 years of successful sales, marketing and operations experience in drug development services. All of us at Aptuit congratulate him as he leads in building a strong business model based on our solid reputation for scientific excellence."

Mr. Needleman began his career at Cambrex, and previously held senior level, global positions at Oxford Asymmetry, ChiRex, Rhodia Pharma Solutions and Arch Pharmalabs. Mr. Needleman joined Aptuit in 2006 as Vice President, Sales and Marketing, and was later promoted to President of API Development and Manufacturing. In 2011, Mr. Needleman was placed in charge of all the company's scientific efforts as President of Aptuit Scientific Operations. Mr. Needleman earned an MBA and BSc in Chemical Engineering from Rensselaer Polytechnic Institute (RPI).

Stu Needleman resides in Trumbull, CT with his wife and daughter. He is active in numerous local and regional organizations, serving on the Boards of Trumbull Babe Ruth baseball and Trumbull Pisces swimming. Stu and his wife are also active supporters of the Strike 3 Foundation for childhood cancer research.

For more information, please contact Maria Garvey, Delfino Marketing at 914-747-1400 or maria@delfino.com.

Aptuit is a global pharmaceutical services company focusing on delivering contract development and manufacturing services and streamlining the drug development process for biotechnology and pharmaceutical innovators. Aptuit's employees deliver an integrated suite of product development services to more than 800 companies worldwide driven by a deep commitment to client service, quality and an unrivaled track record of scientific excellence. The company is partnered with Welsh, Carson, Anderson & Stowe, one of the world's leading private equity investors. For more information about Aptuit, visit www.aptuit.com

Aptuit: engineering a better drug development process through scientific excellence


'/>"/>
SOURCE Aptuit
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aptuit Completes Sale of CTS to Catalent; Reinforces Commitment to Scientific Excellence and Most Comprehensive Early to Mid-Phase Development Capability
2. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
3. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
4. Xytis Names Gordon H. Busenbark as Chief Financial Officer
5. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
6. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
7. California Cryobank Names Richard Jennings President of FamilyCord Division
8. Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
9. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
10. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
11. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... LONDON , March 22, 2017  Ablation ... used for a wide range of purposes, from ... of abnormally conducting cardiac tissue in atrial fibrillation ... procedures is pushing the researchers to innovate and ... The ablation device global market is ...
(Date:3/22/2017)... 2017 Piramal Pharma Solutions (PPS), ... a special event to introduce the new and expanded ... Kentucky . The inaugural event was attended by ... Piramal, and Piramal Pharma Solutions CEO, Vivek ... ...
(Date:3/22/2017)... 2017 National Medical Products announced its ... Innovative Technology contract from Vizient, Inc ., ... country. The contract was based on a recommendation ... in this category who serve on one of ... for technologies that demonstrate an ability to enhance ...
Breaking Medicine Technology:
(Date:3/22/2017)... Birmingham, Ala. (PRWEB) , ... March 22, 2017 ... ... consumer experience solution provider, today announced that its digital marketing solutions have enabled ... their marketing investment in 24 months. , Recognizing the value of a ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Burke Medical ... to translate advances in basic neuroscience at the BMRI labs into new and ... to improve movement, vision, and cognition impaired by stroke, traumatic brain injury, cerebral ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a Long ... Nassau County region, is embarking on a combined charity effort with the Great Neck ... the last 25 years, the Great Neck Breast Cancer Coalition has worked to support ...
(Date:3/22/2017)... Kingston, NC (PRWEB) , ... March 22, 2017 , ... ... planning assistance to families and business professionals throughout the coastal plains region, is initiating ... struggling to overcome cancer. , Dillyn was first diagnosed with leukemia on a Friday ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... patient payments for providers while creating a positive patient experience. , HealthiPASS ... further educates and empowers patients by helping them understand their financial responsibility. ...
Breaking Medicine News(10 mins):